DE602004018142D1 - Pharmazeutische formulierung mit levothyroxin-natrium - Google Patents

Pharmazeutische formulierung mit levothyroxin-natrium

Info

Publication number
DE602004018142D1
DE602004018142D1 DE602004018142T DE602004018142T DE602004018142D1 DE 602004018142 D1 DE602004018142 D1 DE 602004018142D1 DE 602004018142 T DE602004018142 T DE 602004018142T DE 602004018142 T DE602004018142 T DE 602004018142T DE 602004018142 D1 DE602004018142 D1 DE 602004018142D1
Authority
DE
Germany
Prior art keywords
pharmaceutical formulation
levothyroxine sodium
levothyroxine
sodium
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004018142T
Other languages
German (de)
English (en)
Inventor
M Konieczna
Heiner Krohn
Wanda Roman
Hendrik Schlehahn
M A Strozyk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aspen Global Inc
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE602004018142D1 publication Critical patent/DE602004018142D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004018142T 2003-07-10 2004-07-08 Pharmazeutische formulierung mit levothyroxin-natrium Expired - Lifetime DE602004018142D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0316206.2A GB0316206D0 (en) 2003-07-10 2003-07-10 Pharmaceutical formulation
PCT/EP2004/007667 WO2005004849A2 (en) 2003-07-10 2004-07-08 Pharmaceutical formulation comprising levothyroxine sodium

Publications (1)

Publication Number Publication Date
DE602004018142D1 true DE602004018142D1 (de) 2009-01-15

Family

ID=27741962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004018142T Expired - Lifetime DE602004018142D1 (de) 2003-07-10 2004-07-08 Pharmazeutische formulierung mit levothyroxin-natrium

Country Status (28)

Country Link
US (1) US7955621B2 (enExample)
EP (1) EP1643976B1 (enExample)
JP (2) JP4880457B2 (enExample)
KR (1) KR101136655B1 (enExample)
CN (1) CN100430051C (enExample)
AR (1) AR045719A1 (enExample)
AT (1) ATE415949T1 (enExample)
AU (1) AU2004255466B2 (enExample)
BR (1) BRPI0412391B8 (enExample)
CA (1) CA2531853C (enExample)
CO (1) CO5700710A2 (enExample)
DE (1) DE602004018142D1 (enExample)
DK (1) DK1643976T3 (enExample)
ES (1) ES2319193T3 (enExample)
GB (1) GB0316206D0 (enExample)
IL (1) IL172619A (enExample)
IS (1) IS2616B (enExample)
MA (1) MA27898A1 (enExample)
MX (1) MXPA06000353A (enExample)
MY (1) MY140127A (enExample)
NO (1) NO338465B1 (enExample)
NZ (1) NZ544174A (enExample)
PL (1) PL1643976T3 (enExample)
PT (1) PT1643976E (enExample)
RU (1) RU2349345C2 (enExample)
TW (1) TWI329026B (enExample)
WO (1) WO2005004849A2 (enExample)
ZA (1) ZA200510224B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
ATE519480T1 (de) * 2006-01-06 2011-08-15 Intervet Int Bv Konzentrierte flüssige schilddrüsenhormonzusammensetzung
IT1395454B1 (it) * 2009-03-24 2012-09-21 Altergon Sa Composizioni e forme farmaceutiche per somministrazione orale di ormoni tiroidei in grado di contrastare l'azione di agenti sequestranti nel tratto gastrointestinale
ITMI20112066A1 (it) * 2011-11-14 2013-05-15 Altergon Sa Preparazione farmaceutica orale monodose di ormoni tiroidei t3 e t4
US9271951B2 (en) 2012-12-21 2016-03-01 Mylan Inc. Levothyroxine formulation with acacia
WO2014098886A1 (en) * 2012-12-21 2014-06-26 Mylan Inc. Levothyroxine formulation with carrageenan
WO2014098887A1 (en) * 2012-12-21 2014-06-26 Mylan Inc. Levothyroxine formulation with acacia
EP2932963A1 (en) 2014-04-16 2015-10-21 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stable pharmaceutical dosage forms comprising Levothyroxine sodium
JP6168673B2 (ja) 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
WO2017061621A1 (ja) 2015-10-07 2017-04-13 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
WO2018069805A2 (en) 2016-10-10 2018-04-19 Ftf Pharma Private Limited Method for preparation of liquid oral composition of l-thyroxin
RS61998B1 (sr) * 2017-02-03 2021-07-30 Berlin Chemie Ag Sredstvo za oralnu terapiju štitaste žlezde
IT201800003615A1 (it) * 2018-03-15 2019-09-15 Altergon Sa Formulazioni altamente stabili di ormone tiroideo in capsule molli
CN109988076A (zh) * 2019-05-05 2019-07-09 上海葆隆生物科技有限公司 一种左甲状腺素钠杂质及其制备
KR20220085086A (ko) 2020-12-14 2022-06-22 메디케어제약 주식회사 갑상선 기능 저하증을 동반한 대사 증후군을 치료하는 약제학적 복합제제
WO2025181833A1 (en) * 2024-03-01 2025-09-04 Srushti Pharmaceuticals Pvt Ltd Levothyroxine sodium pellets composition and method of preparation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
AU4856093A (en) * 1992-09-22 1994-04-12 Fmc Corporation Product and process of making microcrystalline cellulose
GB9401879D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
DE19541128C2 (de) * 1995-10-27 1997-11-27 Henning Berlin Gmbh & Co Stabilisierte schilddrüsenhormonhaltige Arzneimittel
BR9611306A (pt) * 1995-11-14 1999-12-28 Knoll Pharmaceuticals Co Preparação farmacêutica e, composto farmacêutica estável.
JPH11286456A (ja) * 1998-03-31 1999-10-19 Lion Corp 複合粉体組成物及び錠剤
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications
JP2001064177A (ja) * 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
JP3435664B2 (ja) * 1999-12-08 2003-08-11 ヤンセンファーマ株式会社 口腔内速崩壊型錠剤及びその製造方法
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US6555581B1 (en) * 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods

Also Published As

Publication number Publication date
NO20060208L (no) 2006-01-13
US20070110803A1 (en) 2007-05-17
MA27898A1 (fr) 2006-05-02
AU2004255466B2 (en) 2007-07-26
KR101136655B1 (ko) 2012-04-18
HK1089094A1 (en) 2006-11-24
JP2011213736A (ja) 2011-10-27
WO2005004849A3 (en) 2005-05-06
CO5700710A2 (es) 2006-11-30
IS8287A (is) 2006-02-07
CA2531853A1 (en) 2005-01-20
IL172619A0 (en) 2006-04-10
ES2319193T3 (es) 2009-05-05
GB0316206D0 (en) 2003-08-13
ZA200510224B (en) 2007-09-26
CN1819820A (zh) 2006-08-16
CN100430051C (zh) 2008-11-05
BRPI0412391B1 (pt) 2017-10-31
MY140127A (en) 2009-11-30
NO338465B1 (no) 2016-08-22
JP4880457B2 (ja) 2012-02-22
RU2349345C2 (ru) 2009-03-20
TWI329026B (en) 2010-08-21
NZ544174A (en) 2008-07-31
BRPI0412391B8 (pt) 2021-05-25
BRPI0412391A (pt) 2006-09-19
TW200518785A (en) 2005-06-16
IS2616B (is) 2010-04-15
DK1643976T3 (da) 2009-04-06
CA2531853C (en) 2010-09-14
RU2006104009A (ru) 2006-06-27
ATE415949T1 (de) 2008-12-15
IL172619A (en) 2010-12-30
AU2004255466A1 (en) 2005-01-20
US7955621B2 (en) 2011-06-07
PL1643976T3 (pl) 2009-05-29
AR045719A1 (es) 2005-11-09
MXPA06000353A (es) 2006-03-28
PT1643976E (pt) 2009-03-03
EP1643976B1 (en) 2008-12-03
WO2005004849A2 (en) 2005-01-20
JP2009513530A (ja) 2009-04-02
KR20060065628A (ko) 2006-06-14
EP1643976A2 (en) 2006-04-12

Similar Documents

Publication Publication Date Title
DE602004025950D1 (de) Pharmazeutische formulierung mit lanthanum-verbindungen
DE60332393D1 (de) Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
DE60316323D1 (de) Feste pharmazeutische formulierungen mit telmisartan
DE602004016444D1 (de) Azithromycin enthaltende pharmazeutische Zusammensetzungen mit verringerten Nebenwirkungen
DE602005012107D1 (de) Pharmazeutische formulierungen mit einem antibioti
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
ATE447396T1 (de) Pharmazeutisches vaginales gel mit tenofovir
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DE60209145D1 (de) Pharmazeutische formulierungen mit platinderivaten
DE60316552D1 (de) Tablette mit hohem wirkstoffgehalt
ATE334656T1 (de) Flüssige pharmazeutische zusammensetzung
ATE355271T1 (de) Pharmazeutische zusammensetzung
ATE415949T1 (de) Pharmazeutische formulierung mit levothyroxin- natrium
DE602004014765D1 (de) Pharmazeutische zusammensetzungen mit atorvastatin, hergestellt ohne granulation
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
EP1411904A4 (en) PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE
DE60210139D1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
DE60305728D1 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
ATE477814T1 (de) Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
ATE366128T1 (de) Pharmazeutische zusammensetzung
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE602004024220D1 (de) Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
DE60310526D1 (de) Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: BOETERS & LIECK, 80331 MUENCHEN

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASPEN GLOBAL INCORPORATED, PORT LOUIS, MU